Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the atrial fibrillation market?

In recent years, there has been a swift expansion in the size of the atrial fibrillation market. It is projected to escalate from $13.56 billion in 2024 to $15.14 billion in 2025, with a compound annual growth rate (CAGR) of 11.7%. This growth within the historic period is due to several factors such as heightened awareness and screening initiatives, technological advances in treatment procedures, elevated healthcare spending, ongoing clinical research and drug development, and genetic predisposition.

What will be the atrial fibrillation market size in the future?

The market size of atrial fibrillation is predicted to experience swift expansion in the upcoming years. The growth will see the market worth $24.93 billion in 2029, with a compound annual growth rate (CAGR) of 13.3%. The surge during the projection period can be attributed to factors like increased attention towards stroke prevention, comprehensive patient and physician education programs, worldwide efforts to improve cardiovascular health, rise in electrophysiology procedures, customization in treatment plans, and government-led initiatives aimed at preventing cardiovascular diseases. Noteworthy trends in the forecast period include progress in diagnostic technologies, an increase in instances of atrial fibrillation, innovations in catheter ablation techniques, the advent of novel oral anticoagulants (NOACs), the integration of wearable technologies for monitoring purposes, a widening role of telemedicine in managing AF, and enhancements in implantable devices.

Get your atrial fibrillation market report here!

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

What main drivers are fueling expansion in the atrial fibrillation market?

The anticipated rise in the elderly community is set to propel the atrial fibrillation market. This refers to persons aged 65 and above, who due to several factors such as postural hypotension and issues with balance and gait, are at a higher risk of falling. The age factor and conduction abnormalities can often be observed on the surface electrocardiogram before the commencement of atrial fibrillation (AF) in the majority of elderly patients. For example, as per the World Health Organization, a Switzerland-based specialized wing of the United Nations that deals with international public health, they forecast that by 2030, six people globally will be 60 years of age or older. Notably, there will be an upsurge from 1 billion in 2020 to 1.4 billion people aged 60 or older. By 2050, the global count of individuals 60 or older will double to 2.1 billion, with an additional 426 million people aged 80 or more compared to current figures. Consequently, the expanding geriatric crowd is acting as a catalyst for the atrial fibrillation market growth.

What key areas define the segmentation of the global atrial fibrillation market?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Who are the dominant players expanding their reach in the atrial fibrillation market?

Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

How are evolving market trends shaping atrial fibrillation Strategies?

Top firms in the atrial fibrillation market are introducing innovative products and solutions, like patient-focused clinical decision support systems, to fortify their market presence. These clinical decision support tools (CDST) are either software or electronic systems aimed at helping healthcare professionals make informed and timely patient care decisions. Such tools are designed to consolidate pertinent clinical data from diverse sources. For example, in August 2023, GE HealthCare, a medical technology firm based in the U.S., unveiled CardioVisio, a patient-centric CDST. It supports physicians by providing evidence-based clinical decision assistance based on current atrial fibrillation guidelines and allows visualization of longitudinal data from various sources pertinent to disease progression. CardioVisio helps cardiologists streamline image interpretation and provides an overview of the patient’s cardiac history and healthcare journey, including prior diagnoses, medication, interventions, and accompanying health conditions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

Which regions are emerging as leaders in the atrial fibrillation market?

North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: